Skip to main content

Advertisement

SpringerLink
Log in

Treatment advances in adult immune thrombocytopenic purpura

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by autoantibody-mediated destruction of platelets. The disease generally runs a mild clinical course, though significant morbidity and mortality can occur. Steroids and/or splenectomy are effective in treating the disease in approximately 70% of patients. These treatments have been well established with approximately 50 years of clinical experience. While open splenectomy is the traditional surgical procedure, laparoscopic splenectomy, splenic artery embolization, and splenic irradiation are viable alternatives. For patients who relapse after the above therapies, treatment is more difficult and seldom results in a cure. The goals of therapy involve maintaining a safe platelet count while minimizing toxicities from the treatment. Multiple treatment options exist including corticosteroids, androgens, immunomodulatory drugs, cytotoxic chemotherapy, immunoglobulin preparations, bone marrow transplantation, Helicobacter pylori eradication, and others. While the standard treatment of steroids and splenectomy has changed little over the past decades, a number of promising new therapies on the horizon may soon join the armamentarium upon which the clinician can draw to fight the disease. In this review, we will examine treatment for chronic ITP in adults in the pre-splenectomy, splenectomy, and post-splenectomy settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Ahn YS, Harrington WJ, Seelman RC, Eytel CS (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291:376–380

    CAS  PubMed  Google Scholar 

  2. Ahn YS, Harrington WJ (1977) Treatment of idiopathic thrombocytopenic purpura (ITP). Annu Rev Med 28:299–309

    Article  CAS  PubMed  Google Scholar 

  3. Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med 298:1101–1107

    CAS  PubMed  Google Scholar 

  4. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 308:1396–1399

    CAS  PubMed  Google Scholar 

  5. Ahn YS, Harrington WJ, Mylvaganam R, Allen LM, Pall LM (1984) Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura. Ann Intern Med 100:192–196

    CAS  PubMed  Google Scholar 

  6. Ahn YS, Mylvaganam R, Garcia RO, Kim CI, Palow D, Harrington WJ (1987) Low-dose danazol therapy in idiopathic thrombocytopenic purpura. Ann Intern Med 107:177–181

    CAS  PubMed  Google Scholar 

  7. Ahn YS, Rocha R, Mylvaganam R, Garcia R, Duncan R, Harrington WJ (1989) Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women. Ann Intern Med 111:723–729

    CAS  PubMed  Google Scholar 

  8. Akwari OE, Itani KM, Coleman RE, Rosse WF (1987) Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg 206:529–541

    CAS  PubMed  Google Scholar 

  9. Almagro D (1985) Danazol in idiopathic thrombocytopenic purpura. Acta Haematol 74:120

    CAS  PubMed  Google Scholar 

  10. Ambriz P, Munoz R, Quintanar E, Sigler L, Aviles A, Pizzuto J (1985) Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. Radiology 155:793–796

    CAS  PubMed  Google Scholar 

  11. Andersen JC (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 330:1560–1564

    CAS  PubMed  Google Scholar 

  12. Arruda VR, Annichino-Bizzacchi JM (1996) High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpura. Ann Hematol 73:175–177

    CAS  PubMed  Google Scholar 

  13. Balint JP Jr, Snyder HW Jr, Cochran SK, Jones FR (1991) Long-term response of immune thrombocytopenia to extracorporeal immunoadsorption. Lancet 337:1106

    Google Scholar 

  14. Bartholomew JR, Salgia R, Bell WR (1989) Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid. Arch Intern Med 149:1959–1961

    Article  CAS  PubMed  Google Scholar 

  15. Baumann MA, Menitove JE, Aster RH, Anderson T (1986) Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med 104:808–809

    CAS  PubMed  Google Scholar 

  16. Beardsley DS (2002) Pathophysiology of immune thrombocytopenic purpura. Blood Rev 16:13–14

    Google Scholar 

  17. Bellucci S, Charpak Y, Chastang C, Tobelem G (1988) Low doses v. conventional doses of corticosteroids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 71:1165–1169

    CAS  PubMed  Google Scholar 

  18. Bellucci S, Bordessoule D, Coiffier B, Tabah I (1989) Interferon alpha-2b therapy in adults chronic thrombocytopenic purpura (ITP). Br J Haematol 73:578–579

    CAS  PubMed  Google Scholar 

  19. Ben-Yehuda D, Gillis S, Eldor A (1994) Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol 91:1–6

    CAS  PubMed  Google Scholar 

  20. Berchtold P, McMillan R (1989) Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 74:2309–2317

    CAS  PubMed  Google Scholar 

  21. Blanchette VS, Hogan VA, McCombie NE, Drouin J, Bormanis JD, Taylor R, Rock GA (1984) Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura. Transfusion 24:388–394

    Article  CAS  PubMed  Google Scholar 

  22. Blanchette V (2002) Childhood chronic immune thrombocytopenia (ITP). Blood Rev 16:23–26

    Article  CAS  PubMed  Google Scholar 

  23. Boughton BJ, Smith P, Fielding J, Hawker R, Wilson I, Chandler S, Howie A (1985) Size of spleen rather than amount of platelet sequestration may determine long term responses to splenectomy in adult idiopathic thrombocytopenic purpura. J Clin Pathol 38:1172–1174

    CAS  PubMed  Google Scholar 

  24. Boughton BJ, Chakraverty R, Baglin TP, Simpson A, Galvin G, Rose P, Rohlova B (1988) The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin; its effectiveness, safety and mechanism of action. Clin Lab Haematol 10:275–284

    CAS  PubMed  Google Scholar 

  25. Bouroncle BA, Doan CA (1966) Refractory idiopathic thrombocytopenic purpura treated with azathioprine. N Engl J Med 275:630–635

    CAS  PubMed  Google Scholar 

  26. Bouroncle BA, Doan CA (1969) Treatment of refractory idiopathic thrombocytopenic purpura. JAMA 207:2049–2052

    Article  CAS  PubMed  Google Scholar 

  27. Branda RF, Tate DY, McCullough JJ, Jacob HS (1978) Plasma exchange in the treatment of fulminant idiopathic (autoimmune) thrombocytopenic purpura. Lancet 1:688–690

    CAS  PubMed  Google Scholar 

  28. Brennan MF, Rappeport JM, Moloney WC, Wilson RE (1975) Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Am J Surg 129:490–492

    CAS  PubMed  Google Scholar 

  29. Brox AG, Howson-Jan K, Fauser AA (1988) Treatment of idiopathic thrombocytopenic purpura with ascorbate. Br J Haematol 70:341–344

    CAS  PubMed  Google Scholar 

  30. Buchanan GR (2001) Idiopathic thrombocytopenic purpura in childhood. Pediatr Ann 30:527–533

    CAS  PubMed  Google Scholar 

  31. Buelli M, Cortelazzo S, Viero P, Minetti B, Comotti B, Bassan R, Barbui T (1985) Danazol for the treatment of idiopathic thrombocytopenic purpura. Acta Haematol 74:97–98

    CAS  PubMed  Google Scholar 

  32. Burton IE, Roberts BE, Child JA, Montgomery DA, Raper CG (1976) Responses to vincristine in refractory idiopathic thrombocytopenic purpura. Br Med J 2:918

    CAS  PubMed  Google Scholar 

  33. Buskard N, Rock G, Nair R (1998) The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group. Transfus Sci 19:295–300

    Article  CAS  PubMed  Google Scholar 

  34. Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW (1983) Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 62:480–486

    CAS  PubMed  Google Scholar 

  35. Bussel JB, Pham LC, Aledort L, Nachman R (1988) Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 72:121–127

    CAS  PubMed  Google Scholar 

  36. Bussel JB, Saal S, Gordon B (1988) Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion 28:38–41

    Article  CAS  PubMed  Google Scholar 

  37. Bussel JB, Fitzgerald-Pedersen J, Feldman C (1990) Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: more is not always better. Am J Hematol 33:184–188

    CAS  PubMed  Google Scholar 

  38. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 77:1884–1893

    CAS  PubMed  Google Scholar 

  39. Calverley DC, Jones GW, Kelton JG (1992) Splenic radiation for corticosteroid-resistant immune thrombocytopenia. Ann Intern Med 116:977–981

    CAS  PubMed  Google Scholar 

  40. Caplan SN, Berkman EM (1976) Immunosuppressive therapy of idiopathic thrombocytopenic purpura. Med Clin North Am 60:971–986

    CAS  PubMed  Google Scholar 

  41. Carr JM, Kruskall MS, Kaye JA, Robinson SH (1986) Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 80:1051–1054

    CAS  PubMed  Google Scholar 

  42. Caulier MT, Darloy F, Rose C, Camier G, Morel P, Bauters F, Fenaux P (1995) Splenic radiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy. Br J Haematol 91:208–211

    CAS  PubMed  Google Scholar 

  43. Cervantes F, Montserrat E, Rozman C, Diumenjo C, Feliu E, Granena A (1980) Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients. Postgrad Med J 56:711–714

    CAS  PubMed  Google Scholar 

  44. Chirletti P, Cardi M, Barillari P, Vitale A, Sammartino P, Bolognese A, Caiazzo R, Ricci M, Muttillo IA, Stipa V (1992) Surgical treatment of immune thrombocytopenic purpura. World J Surg 16:1001–1004

    CAS  PubMed  Google Scholar 

  45. Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS, Sohn SK, Shin DG, Ryoo HM, Lee KH, Lee JJ, Chung IJ, Kim HJ, Kwak JY, Yim CY, Ahn JS, Lee JA, Park YS (2001) Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol 66:197–202

    Article  CAS  PubMed  Google Scholar 

  46. Clark AL, Gall SA (1997) Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 176:241–253

    CAS  PubMed  Google Scholar 

  47. Coon WW (1987) Splenectomy for idiopathic thrombocytopenic purpura. Surg Gynecol Obstet 164:225–229

    CAS  PubMed  Google Scholar 

  48. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T (1991) High risk of severe bleeding in aged patients with chronic thrombocytopenic purpura. Blood 77:31–33

    CAS  PubMed  Google Scholar 

  49. Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51:S2-S8

    CAS  Google Scholar 

  50. Damashek W, Rubio F, Mahoney JP, Reeves WH, Burgin LA (1958) Treatment of idiopathic thrombocytopenic purpura with prednisone. JAMA 166:1805–1815

    CAS  Google Scholar 

  51. Demiroglu H, Dundar S (1997) High-dose pulsed dexamethasone for immune thrombocytopenia. N Engl J Med 337:425–427

    Article  CAS  PubMed  Google Scholar 

  52. Dhawan A, Mieli-Vergani G (2000) Mycophenolate mofetil—a new treatment for autoimmune hepatitis? J Hepatol 33:480–481

    Article  CAS  PubMed  Google Scholar 

  53. Di Paola JA, Buchanan GR (2002) Immune thrombocytopenic purpura. Pediatr Clin North Am 49:911–928

    PubMed  Google Scholar 

  54. Di Fino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69:430–442

    CAS  PubMed  Google Scholar 

  55. Doan CA, Bouroncle BA, Wiseman BK (1960) Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 53:861

    Google Scholar 

  56. Dubbeld P, van der Heul C, Hillen HF (1991) Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP). Neth J Med 39:6–10

    CAS  PubMed  Google Scholar 

  57. Dubbeld P, Hillen HF, Schouten HC (1994) Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP). Eur J Haematol 52:233–235

    CAS  PubMed  Google Scholar 

  58. Durand JM, Lefevre P, Hovette P, Mongin M, Soubeyrand J (1991) Dapsone for idiopathic thrombocytopenic purpura in elderly patients. Br J Haematol 78:459–460

    CAS  PubMed  Google Scholar 

  59. Dzik WH, Duncan LM (1994) Case records of the Massachusetts General Hospital. A 55-year-old woman with a skin rash and hemiparesis after staphylococcal protein A column therapy. N Engl J Med 331:792

    Article  PubMed  Google Scholar 

  60. Edelmann DZ, Knobel B, Virag I, Meytes D (1990) Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura. Postgrad Med J 66:827–830

    CAS  PubMed  Google Scholar 

  61. Emilia G, Messora C, Longo G, Bertesi M (1996) Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol 93:341–344

    CAS  PubMed  Google Scholar 

  62. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G (2001) Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 97:812–814

    Article  CAS  PubMed  Google Scholar 

  63. Emilia G, Morselli M, Luppi M, Longo G, Marasca R, Gandini G, Ferrara L, D'Apollo N, Potenza L, Bertesi M, Torelli G (2002) Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood 99:1482–1485

    Article  CAS  PubMed  Google Scholar 

  64. Emilia G, Luppi M, Morselli M, Potenza L, D'Apollo N, Torelli G (2002) Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Br J Haematol 118:1198–1199

    Article  PubMed  Google Scholar 

  65. Fabris F, Zanatta N, Casonato A, Randi ML, Luzzatto G, Girolami A (1989) Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haematol 81:28–33

    CAS  PubMed  Google Scholar 

  66. Fabrizio F, Luzzatto G, Ramon R, Randi ML, De Silvestro G, Girolami A (2000) Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases. Haematologica 85:889–890

    CAS  PubMed  Google Scholar 

  67. Facon T, Caulier MT, Fenaux P, Plantier I, Marchandise X, Ribet M, Jouet JP, Bauters F (1992) Accessory spleen in recurrent chronic immune thrombocytopenic purpura. Am J Hematol 41:184–189

    CAS  PubMed  Google Scholar 

  68. Facon T, Caulier MT, Wattel E, Jouet JP, Bauters F, Fenaux P (1994) A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br J Haematol 86:678–680

    CAS  PubMed  Google Scholar 

  69. Fenaux P, Caulier MT, Hirschauer MC, Beuscart R, Goudemand J, Bauters F (1989) Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases. Eur J Haematol 42:259–264

    CAS  PubMed  Google Scholar 

  70. Fenaux P, Quiquandon I, Huart JJ, Caulier MT, Bauters F (1990) The role of danazol in the treatment of refractory idiopathic thrombocytopenic purpura: a report of 22 cases. Nouv Rev Fr Hematol 32:143–146

    CAS  PubMed  Google Scholar 

  71. Fenaux P, Quiquandon I, Caulier MT, Simon M, Walter MP, Bauters F (1990) Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases. Blut 60:238–241

    CAS  PubMed  Google Scholar 

  72. Figueroa M, McMillan R (1993) 2-Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura. Blood 81:3484–3485

    CAS  PubMed  Google Scholar 

  73. Figueroa M, Gehlsen J, Hammond D, Ondreyco S, Piro L, Pomeroy T, Williams F, McMillan R (1993) Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med 328:1226–1229

    Article  CAS  PubMed  Google Scholar 

  74. Fine JD (1995) Management of acquired bullous skin diseases. N Engl J Med 333:1475–1484

    Article  CAS  PubMed  Google Scholar 

  75. Flores A, Carles J, Junca J, Abella E (1990) Danazol therapy in chronic immune thrombocytopenic purpura. Eur J Haematol 45:109–110

    CAS  PubMed  Google Scholar 

  76. Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94:909–913

    CAS  PubMed  Google Scholar 

  77. Fujimura K, Takafuta T, Kuriya S, Abe T, Akatsuka J, Yasunaga K, Uchida T, Kawakita M, Kitamura K, Nomura T, Kuramoto A (1996) Recombinant human interferon alpha-2b (rh IFN alpha-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP). Am J Hematol 51:37–44

    Article  CAS  PubMed  Google Scholar 

  78. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 352:878

    CAS  Google Scholar 

  79. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40

    CAS  PubMed  Google Scholar 

  80. Giagounidis AA, Anhuf J, Schneider P, Germing U, Sohngen D, Quabeck K, Aul C (2002) Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monocloncal antibody rituximab: a pilot study. Eur J Haematol 69:95–100

    Article  CAS  PubMed  Google Scholar 

  81. Gibson J, Rickard KA, Bautovich G, May J, Kronenberg H (1986) Management of splenectomy failures in chronic immune thrombocytopenic purpura: role of accessory splenectomy. Aust N Z J Med 16:695–698

    CAS  PubMed  Google Scholar 

  82. Godeau B, Bierling P (1990) Treatment of chronic autoimmune thrombocytopenic purpura with ascorbate. Br J Haematol 75:289–290

    CAS  PubMed  Google Scholar 

  83. Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P (1993) Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 82:1415–1421

    CAS  PubMed  Google Scholar 

  84. Godeau B, Oksenhendler E, Bierling P (1993) Dapsone for autoimmune thrombocytopenic purpura. Am J Hematol 44:70–72

    CAS  PubMed  Google Scholar 

  85. Godeau B, Zini JM, Schaeffer A, Bierling P (1995) High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids. Am J Hematol 48:282–284

    CAS  PubMed  Google Scholar 

  86. Godeau B, Durand JM, Roudot-Thoraval F, Tenneze A, Oksenhendler E, Kaplanski G, Schaeffer A, Bierling P (1997) Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br J Haematol 97:336–339

    CAS  PubMed  Google Scholar 

  87. Godeau B, Caulier MT, Decuypere L, Rose C, Schaeffer A, Bierling P (1999) Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. Br J Haematol 107:716–719

    CAS  PubMed  Google Scholar 

  88. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G (1999) Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica 84:283–284

    CAS  PubMed  Google Scholar 

  89. Gringeri A, Cattaneo M, Santagostino E, Mannucci PM (1992) Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 80:337–340

    CAS  PubMed  Google Scholar 

  90. Gugliotta L, Isacchi G, Guarini A, Ciccone F, Motta MR, Lattarini C, Bachetti G, Mazzucconi MG, Baccarani M, Mandelli F, Tura S (1981) Chronic idiopathic thrombocytopenic purpura (ITP): site of platelet sequestration and results of splenectomy. A study of 197 patients. Scand J Haematol 26:407–412

    CAS  PubMed  Google Scholar 

  91. Guthrie TH Jr, Brannan DP, Prisant LM (1988) Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 296:17–21

    PubMed  Google Scholar 

  92. Guthrie TH Jr, Oral A (1989) Immune thrombocytopenic purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients. Semin Hematol 26:3–9

    PubMed  Google Scholar 

  93. Guze BH, Hawkins R (1988) The utility of SPECT liver-spleen imaging in the evaluation of a possible accessory spleen. Clin Nucl Med 13:496–497

    CAS  PubMed  Google Scholar 

  94. Hernandez F, Linares M, Colomina P, Pastor E, Cervero A, Perez A, Perella M (1995) Dapsone for refractory chronic idiopathic thrombocytopenic purpura. Br J Haematol 90:473–475

    CAS  PubMed  Google Scholar 

  95. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T (2003) Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 82:30–32

    CAS  PubMed  Google Scholar 

  96. Howard J, Hoffbrand AV, Prentice HG, Mehta A (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemic and auto-immune thrombocytopenic purpura. Br J Haematol 117:712–715

    Article  CAS  PubMed  Google Scholar 

  97. Hudson JG, Yates P, Scott GL (1992) Further concern over use of alpha-interferon in immune thrombocytopenic purpura. Br J Haematol 82:630

    CAS  PubMed  Google Scholar 

  98. Huhn RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME, Kimball J, Greene A, Hansmann K, Gratwohl A, Young N, Barrett AJ, Dunbar CE (2003) High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 101:71–77

    Article  CAS  PubMed  Google Scholar 

  99. Iannaccaro P, Molica S, Santoro R, Muleo G, Emofilia C (1992) Recombinant alpha-2b interferon in refractory idiopathic immune thrombocytopenia. Eur J Haematol 48:271

    CAS  PubMed  Google Scholar 

  100. Ikkala E, Kivilaakso E, Kotilainen M, Hastbacka J (1978) Treatment of idiopathic thrombocytopenic purpura in adults. Long-term results in a series of 41 patients. Ann Clin Res 10:83–86

    CAS  PubMed  Google Scholar 

  101. Isbister JP, Biggs JC, Penny R (1978) Experience with large volume plasmapheresis in malignant paraproteinaemia and immune disorders. Aust N Z J Med 8:154–164

    CAS  PubMed  Google Scholar 

  102. Iyori H, Bessho F, Ookawa H, Konishi S, Shirahata A, Miyazaki S, Fujisawa K, Akatsuka J (2000) Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. Ann Hematol 79:691–695

    Article  CAS  PubMed  Google Scholar 

  103. Jacobs P, Wood L, Novitzky N (1994) Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial. Am J Med 97:55–59

    CAS  PubMed  Google Scholar 

  104. Jarque I, Andreu R, Llopis I, de la Rubia J, Gomis F, Senent L, Jimenez C, Martin G, Martinez JA, Sanz GF, Ponce J, Sanz MA (2001) Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 115:1002–1003

    Article  CAS  PubMed  Google Scholar 

  105. Jubelirer SJ (1993) Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura. Am J Hematol 43:44–46

    CAS  PubMed  Google Scholar 

  106. Julia A, Araguas C, Rossello J, Bueno J, Domenech P, Olona M, Guardia R, Petit J, Flores A (1990) Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 76:250–255

    CAS  PubMed  Google Scholar 

  107. Kabisch A, Kroll H, Wedi B, Kiefel V, Pralle H, Mueller-Eckhardt C (1994) Severe adverse effects of protein A immunoadsorption. Lancet 343:116

    CAS  Google Scholar 

  108. Kaplan C (2001) Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy. Transfus Clin Biol 8:311–314

    Article  CAS  PubMed  Google Scholar 

  109. Kappers-Klunne MC, van't Veer MB (2001) Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy. Br J Haematol 114:121–125

    Article  CAS  PubMed  Google Scholar 

  110. Karpatkin S (1980) Autoimmune thrombocytopenic purpura. Blood 56:329–343

    CAS  PubMed  Google Scholar 

  111. Katkhouda N, Hurwitz MB, Rivera RT, Chandra M, Waldrep DJ, Gugenheim J, Mouiel J (1998) Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 228:568–578

    Article  CAS  PubMed  Google Scholar 

  112. Katkhouda N, Mavor E (2000) Laparoscopic splenectomy. Surg Clin North Am 80:1285–1297

    CAS  PubMed  Google Scholar 

  113. Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747–755

    CAS  PubMed  Google Scholar 

  114. Kaznelson P (1916) Verschwinden der hämorrhagischen Diathese bei einem Falle von essentieller Thrombopenie nach Millzextirpation. Wien Klin Wochenschr 29:1451

    Google Scholar 

  115. Kelton JG, McDonald JW, Barr RM, Walker I, Nicholson W, Neame PB, Hamid C, Wong TY, Hirsh J (1981) The reversible binding of vinblastine to platelets: implications for therapy. Blood 57:431–438

    Google Scholar 

  116. Kelton JG (2002) Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 16:43–46

    Google Scholar 

  117. Kimura F, Itoh H, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Ohtsuka M, Shimizu Y, Shimamura F, Miyazaki M (2002) Long-term results of initial and repeated partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR Am J Roentgenol 179:1323–1326

    PubMed  Google Scholar 

  118. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G, Hirayama Y, Sato Y, Niitsu Y (2002) Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic refractory thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 118:584–588

    Article  PubMed  Google Scholar 

  119. Kondo H, Iseki T, Goto S, Takaso T, Ohto M, Okuda K (1992) Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy. Int J Hematol 55:293–300

    CAS  PubMed  Google Scholar 

  120. Kotlarek-Haus S, Podolak-Dawidziak M (1987) Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids. Folia Haematol Int Mag Klin Morphol Blutforsch 114:768–776

    CAS  PubMed  Google Scholar 

  121. Kruczynski A, Hill BT (2001) Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 40:159–173

    Article  CAS  PubMed  Google Scholar 

  122. Kumakura S, Ishikura H, Tsumura H, Endo J, Tsunematsu T (1993) A favourable effect of long-term alpha-interferon therapy in refractory idiopathic thrombocytopenic purpura. Br J Haematol 85:805–807

    CAS  PubMed  Google Scholar 

  123. Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81:312–319

    Article  CAS  PubMed  Google Scholar 

  124. Kurlander R, Coleman RE, Moore J, Gockerman J, Rosse W, Siegal R (1987) Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults. Am J Med 83:17–24

    CAS  Google Scholar 

  125. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y (2002) Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol 168:3675–3682

    CAS  PubMed  Google Scholar 

  126. Kuwana M, Kawakami Y, Ikeda Y (2003) Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura. Blood 101:621–623

    Article  CAS  PubMed  Google Scholar 

  127. Laros RK JR, Penner JA (1971) "Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide. JAMA 215:445–449

    Article  PubMed  Google Scholar 

  128. Laveder F, Marcolongo R, Zamboni S (1995) Thrombocytopenic purpura following treatment with danazol. Br J Haematol 90:970–971

    CAS  PubMed  Google Scholar 

  129. Law C, Marcaccio M, Tam P, Heddle N, Kelton JG (1997) High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 336:1494–1498

    CAS  PubMed  Google Scholar 

  130. Leung AY, Chim CS, Kwong YL, Lie AK, Au WY, Liang R (2001) Clinicopathologic and prognostic features of chronic idiopathic thrombocytopenic purpura in adult Chinese patients: an analysis of 220 cases. Ann Hematol 80:384–386

    Article  CAS  PubMed  Google Scholar 

  131. Lim SH, Hale G, Marcus RE, Waldmann H, Baglin TP (1993) CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. Br J Haematol 84:542–544

    CAS  PubMed  Google Scholar 

  132. Lim SH, Kell J, al-Sabah A, Bashi W, Bailey-Wood R (1997) Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 349:475

    CAS  PubMed  Google Scholar 

  133. Linares M, Cervero A, Sanchez M, Garcia S, Miguel-Sosa A, Miguel-Garcia A, Miguel-Borja JM (1988) Slow infusion of vincristine in the treatment of refractory thrombocytopenic purpura. Acta Haematol 80:173–174

    CAS  PubMed  Google Scholar 

  134. Linares M, Cervero A, Colomina P, Pastor E, Lopez A, Perez A, Perella M, Carbonell F (1995) Chronic idiopathic thrombocytopenic purpura in the elderly. Acta Haematol 93:80–82

    CAS  PubMed  Google Scholar 

  135. Macpherson AI, Richmond J (1975) Planned splenectomy in treatment of idiopathic thrombocytopenic purpura. Br Med J 1:64–66

    CAS  PubMed  Google Scholar 

  136. Manoharan A (1986) Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura. Am J Hematol 21:135–138

    CAS  PubMed  Google Scholar 

  137. Manoharan A (1987) Danazol therapy in patients with immune cytopenias. Aust N Z J Med 17:613–614

    CAS  PubMed  Google Scholar 

  138. Manoharan A (1991) Targeted-immunosuppression with vincristine infusion in the treatment of immune thrombocytopenia. Aust N Z J Med 21:405–407

    CAS  PubMed  Google Scholar 

  139. Marder VJ, Nusbacher J, Anderson FW (1981) One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 21:291–298

    CAS  PubMed  Google Scholar 

  140. Mazzucconi MG, Francesconi M, Fidani P, Di Nucci G, Gandolfo GM, Afeltra A, Masala C, Di Prima M, Rocchi G, Resta S, et al. (1985) Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol. Haematologica 70:329–336

    CAS  PubMed  Google Scholar 

  141. Mazzucconi MG, Francesconi M, Falcione E, Ferrari A, Gandolfo GM, Ghirardini A, Tirindelli MC (1987) Danazol therapy in refractory chronic immune thrombocytopenic purpura. Acta Haematol 77:45–47

    CAS  PubMed  Google Scholar 

  142. Mazzucconi MG, Arista MC, Peraino M, Chistolini A, Felici C, Francavilla V, Macale E, Conti L, Gandolfo GM (1999) Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol 62:219–222

    CAS  PubMed  Google Scholar 

  143. McFarland J (2002) Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev 16:1–2

    Article  CAS  PubMed  Google Scholar 

  144. McMillan R, Longmire RL, Yelenosky R, Donnell RL, Armstrong S (1974) Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N Engl J Med 291:812–817

    CAS  PubMed  Google Scholar 

  145. McMillan R (2001) Long-term outcomes after treatment for refractory immune thrombocytopenic purpura. N Engl J Med 344:1402–1403

    Article  CAS  PubMed  Google Scholar 

  146. McVerry BA, Auger M, Bellingham AJ (1985) The use of danazol in the management of chronic immune thrombocytopenic purpura. Br J Haematol 61:145–148

    CAS  PubMed  Google Scholar 

  147. Medeiros D, Buchanan GR (2000) Idiopathic thrombocytopenic purpura: beyond consensus. Curr Opin Pediatr 12:4–9

    Article  CAS  PubMed  Google Scholar 

  148. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P (2002) Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med 162:1033–1036

    PubMed  Google Scholar 

  149. Mintz SJ, Petersen SR, Cheson B, Cordell LJ, Richards RC (1981) Splenectomy for immune thrombocytopenic purpura. Arch Surg 116:645–650

    CAS  PubMed  Google Scholar 

  150. Miyazaki M, Itoh H, Kaiho T, Ohtawa S, Ambiru S, Hayashi S, Nakajima N, Oh H, Asai T, Iseki T (1994) Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR Am J Roentgenol 163:123–126

    CAS  PubMed  Google Scholar 

  151. Moroni G, Maccario M, Fargion S, Ponticelli C (1997) Severe and prolonged jaundice in a lupus nephritis patients treated with cyclophosphamide. Nephrol Dial Transplant 12:793–796

    Article  CAS  PubMed  Google Scholar 

  152. Mozes MF, Spigos DG, Pollak R, Abejo R, Pavel DG, Tan WS, Jonasson O (1984) Partial splenic embolization, an alternative to splenectomy—results of a prospective, randomized study. Surgery 96:694–702

    CAS  PubMed  Google Scholar 

  153. Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R (2001) Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Hematol 66:75–79

    Article  CAS  PubMed  Google Scholar 

  154. Nagahama M, Nomura S, Kanazawa S, Ozaki Y, Kagawa H, Fukuhara S (2002) Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura. Eur J Haematol 69:303–308

    Article  CAS  PubMed  Google Scholar 

  155. Najean Y, Ardaillou N (1971) The sequestration site of platelets in idiopathic thrombocytopenic purpura: its correlation with the results of splenectomy. Br J Haematol 21:153–164

    CAS  PubMed  Google Scholar 

  156. Nalli G, Sajeva MR, Maffe GC, Ascari E (1988) Danazol therapy for idiopathic thrombocytopenic purpura (ITP). Haematologica 73:55–57

    CAS  PubMed  Google Scholar 

  157. Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB (2001) A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 112:1076–1078

    Article  CAS  PubMed  Google Scholar 

  158. Nielsen OH, Vainer B, Rask-Madsen J (2001) Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15:1699–1708

    Article  CAS  PubMed  Google Scholar 

  159. Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y (2002) Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 100:728–730

    Article  CAS  PubMed  Google Scholar 

  160. Novitzky N, Wood L, Jacobs P (1992) Treatment of refractory immune thrombocytopenic purpura with ascorbate. South Afr Med J 81:44–45

    CAS  Google Scholar 

  161. Nugent DJ (2002) Childhood immune thrombocytopenic purpura. Blood Rev 16:27–29

    Article  CAS  PubMed  Google Scholar 

  162. Oral A, Nusbacher J, Hill JB, Lewis JH (1984) Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults. Am J Med 76:187–192

    CAS  Google Scholar 

  163. Oyama Y, Papadopoulos EB, Miranda M, Traynor AE, Burt RK (2001) Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 28:903–905

    Article  CAS  PubMed  Google Scholar 

  164. Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood 64:1179–1183

    CAS  PubMed  Google Scholar 

  165. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549–2554

    Article  CAS  PubMed  Google Scholar 

  166. Proctor SJ, Jackson G, Carey P, Stark A (1988) Short-course alpha-interferon therapy in severe unresponsive immune thrombocytopenic purpura. Lancet 1:947

    CAS  Google Scholar 

  167. Proctor SJ, Jackson G, Carey P, Stark A, Finney R, Saunders P, Summerfield G, Maharaj D, Youart A (1989) Improvement of platelet counts in steroid-unresponsive idiopathic thrombocytopenic purpura after short-course therapy with recombinant alpha-2b interferon. Blood 74:1894–1897

    CAS  PubMed  Google Scholar 

  168. Proctor SJ (1991) Alpha interferon therapy in the treatment of idiopathic thrombocytopenic purpura. Eur J Cancer 27:S63-S68

    PubMed  Google Scholar 

  169. Quintini G, Barbera V, Dieli M, Marino C, Mariani G (2000) Prolonged response of chronic immune thrombocytopenic purpura (ITP) to extracorporeal immunoadsorption. Int J Artif Organs 23:407–408

    CAS  PubMed  Google Scholar 

  170. Quiquandon I, Fenaux P, Caulier MT, Pagniez D, Huart JJ, Bauters F (1990) Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol 74:223–228

    CAS  PubMed  Google Scholar 

  171. Rabinowe SN, Miller KB (1987) Danazol-induced thrombocytopenia. Br J Haematol 65:383–384

    CAS  PubMed  Google Scholar 

  172. Radaelli F, Faccini P, Goldaniga M, Guggiari E, Pozzoli E, Maiolo AT, Ciani A, Pogliani EM (2000) Factors predicting response to splenectomy in adults patients with idiopathic thrombocytopenic purpura. Haematologica 85:1040–1044

    CAS  PubMed  Google Scholar 

  173. Raetz E, Beatty PG, Adams RH (1997) Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 20:427–429

    Article  CAS  PubMed  Google Scholar 

  174. Reiner A, Gernsheimer T, Slichter SJ (1995) Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 85:351–358

    CAS  PubMed  Google Scholar 

  175. Rocco MV, Stein RS (1984) Prognostic factors for splenectomy response in adult idiopathic thrombocytopenic purpura. South Med J 77:983–987

    CAS  PubMed  Google Scholar 

  176. Rosenthal AK, Klausmeier M, Cronin ME, McLaughlin JK (2000) Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature. Am J Clin Oncol 23:581–583

    Article  CAS  PubMed  Google Scholar 

  177. Rudowsky WJ (1985) Accessory spleens: clinical significance with particular reference to the recurrence of idiopathic thrombocytopenic purpura. World J Surg 9:422–430

    PubMed  Google Scholar 

  178. Ruivard M, Caulier MT, Vantelon JM, Tournilhac O, Schaeffer A, Godeau B, Bierling P (1999) The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol 105:1130–1132

    Article  CAS  PubMed  Google Scholar 

  179. Salama A, Kiefel V, Mueller-Eckhardt C (1986) Efffect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 22:241–250

    CAS  PubMed  Google Scholar 

  180. Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 89:2689–2700

    CAS  PubMed  Google Scholar 

  181. Scaradavou A (2000) Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: the New York Hospital experience. Semin Hematol 37:S42-S44

    Google Scholar 

  182. Schneider P, Wehmeier A, Schneider W (1997) High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 337:1087–1088

    Article  CAS  PubMed  Google Scholar 

  183. Schwartz SI, Hoepp LM, Sachs S (1980) Splenectomy for thrombocytopenia. Surgery 88:497–506

    CAS  PubMed  Google Scholar 

  184. Sekreta CM, Baker DE (1996) Interferon alfa therapy in adults with chronic idiopathic thrombocytopenic purpura. Ann Pharmacother 30:1176–1179

    CAS  PubMed  Google Scholar 

  185. Simon M, Jouet JP, Fenaux P, Pollet JP, Walter MP, Bauters F (1987) The treatment of adult idiopathic thrombocytopenic purpura. Infusion of vinblastine in ITP. Eur J Haematol 39:193–196

    CAS  PubMed  Google Scholar 

  186. Skoda RC, Tichelli A, Tyndall A, Hoffmann T, Gillessen S, Gratwohl A (1997) Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. Br J Haematol 99:56–57

    CAS  PubMed  Google Scholar 

  187. Snyder HW Jr, Cochran SK, Balint JP Jr, Bertram JH, Mittelman A, Guthrie TH Jr, Jones FR (1992) Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 79:2237–2245

    PubMed  Google Scholar 

  188. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F, Sciarra A, Perrotti AP, Adomo G, Amadori S, et al. (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98:436–442

    Google Scholar 

  189. Stasi R, Pagana A, Stipa E, Amadori S (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98:952–957

    Article  CAS  PubMed  Google Scholar 

  190. Stasi R, Stipa E, Forte V, Meo P, Amadori S (2002) Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood 99:3872–3873

    Article  CAS  PubMed  Google Scholar 

  191. Strother SV, Zuckerman KS, LoBuglio AF (1984) Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med 144:2198–2200

    Article  CAS  PubMed  Google Scholar 

  192. Sussman LN (1967) Azathioprine in refractory idiopathic thrombocytopenic purpura. JAMA 202:259–263

    Article  CAS  PubMed  Google Scholar 

  193. Tanoue K, Okita K, Akahoshi T, Konishi K, Gotoh N, Tsutsumi N, Tomikawa M, Hashizume M (2002) Laparoscopic splenectomy for hematologic diseases. Surgery 131:S318-S323

    Article  PubMed  Google Scholar 

  194. Thompson RL, Moore RA, Hess CE, Wheby MS, Leavell BS (1972) Idiopathic thrombocytopenic purpura. Long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 130:730–734

    CAS  PubMed  Google Scholar 

  195. Toyama K, Ohyashiki K, Nehashi Y, Ohyashiki JH (1990) Ascorbate for the treatment of idiopathic thrombocytopenic purpura. Br J Haematol 70:623–625

    Google Scholar 

  196. Tsiotos G, Schlinkert RT (1997) Laparoscopic splenectomy for immune thrombocytopenic purpura. Arch Surg 132:642–646

    CAS  PubMed  Google Scholar 

  197. Uchino H, Yasunaga K, Akatsuka J (1984) A cooperative clinical trial of high-dose immunoglobulin therapy in 177 cases of idiopathic thrombocytopenic purpura. Thromb Haemost 51:182–185

    CAS  PubMed  Google Scholar 

  198. Van der Beek-Boter JW, van Oers MH, von dem Borne AE, Klaassen RJ (1992) Ascorbate for the treatment of ITP. Eur J Haematol 48:61–62

    PubMed  Google Scholar 

  199. Vanrenterghem YF (1999) Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine? Curr Opin Nephrol Hypertens 8:669–674

    Article  CAS  PubMed  Google Scholar 

  200. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M, Zanetti F, Pizzolo G (2002) Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 87:1177–1179

    PubMed  Google Scholar 

  201. Verhoef GE, Boonen S, Boogaerts MA (1990) Ascorbate for the treatment of refractory idiopathic thrombocytopenic purpura. Br J Haematol 74:234–235

    CAS  PubMed  Google Scholar 

  202. Verlin M, Laros RK Jr, Penner JA (1976) Treatment of refractory idiopathic thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1:97–104

    CAS  PubMed  Google Scholar 

  203. Vianelli N, Tazzari PL, Baravelli S, Ricci F, Valdre L, Tura S (1998) Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura. Haematologica 83:761–763

    CAS  PubMed  Google Scholar 

  204. Vianelli N, Valdre L, Fiacchini M, de Vivo A, Gugliotta L, Catani L, Lemoli RM, Poli M, Tura S (2001) Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 86:504–509

    CAS  PubMed  Google Scholar 

  205. Weinerman B, Maxwell I, Hryniuk W (1974) Intermittent cyclophosphamide treatment of autoimmune thrombocytopenia. Can Med Assoc J 111:1100–1102

    CAS  PubMed  Google Scholar 

  206. Weir AB 3rd, Poon MC, McGowan EI (1980) Plasma exchange in idiopathic thrombocytopenic purpura. Arch Intern Med 140:1101–1103

    Article  PubMed  Google Scholar 

  207. Whipple AO (1926) Splenectomy as a therapeutic measure in thrombocytopenic purpura haemorrhagica. Surg Gynecol Obstet 42:329

    Google Scholar 

  208. Willis F, Marsh JC, Bevan DH, Killick SB, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldmann H, Gordon-Smith EC (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114:891–898

    Article  CAS  PubMed  Google Scholar 

  209. Win N, Matthey F, Davies SC (1990) Ascorbate for the treatment of idiopathic thrombocytopenic purpura. Br J Haematol 75:626

    Google Scholar 

  210. Yatscoff RW, Aspeslet LJ (1998) The monitoring of immunosuppressive drugs: a pharmacodynamic approach. Ther Drug Monit 20:459–463

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Hematology, Mayo Clinic, 200 First St. SW, Mayo Bldg W10 Hematology, Rochester, MN 55905, USA

    M. R. Huber, S. Kumar & A. Tefferi

Authors
  1. M. R. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. R. Huber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huber, M.R., Kumar, S. & Tefferi, A. Treatment advances in adult immune thrombocytopenic purpura. Ann Hematol 82, 723–737 (2003). https://doi.org/10.1007/s00277-003-0732-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0732-z

Keywords

Search

Navigation